Monash secures more than $13m in NHMRC Ideas Grants in neuroscience and mental research
Monash Medicine, Nursing and Health Sciences has been awarded more than $13 million in funding across 13 neuroscience and mental health projects in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.
Federal Minister for Health and Aged Care the Hon Greg Hunt MP announced the grants as part of $239 million in funding for 248 research projects, which will help advance understanding of a wide range of health and medical issues faced by Australians.
The Ideas Grant scheme is designed to support innovative research projects addressing a specific question, and provide particular opportunities for early and mid-career researchers. Research projects funded include exploring the effects of early exposure from bushfires, sleep, as well epilepsy management.
“By bringing together our world-class expertise from across our University, Monash continues to cultivate a culture and environment that supports research excellence in neuroscience and mental health, enabling us to tackle these complex challenges, and ultimately save and transform lives,” says Professor Terence O’Brien, Chair of Medicine and Head at Central Clinical School and lead of the Monash Neuroscience Executive team.
“Congratulations to all of our neuroscience and mental health researchers who have been awarded funding.”
Neuroscience and mental health projects funded under the 2021 Ideas Grants scheme include:
The effects of early exposure to bushfires on adult brain structure and function
Dr Farshad Alizadeh Mansouri from Monash Biomedicine Discovery Institute
Artificial Intelligence to Understand and Predict Chronic Subdural Haematoma Evolution
Dr Shalini Amukotuwa from School of Clinical Sciences at Monash Health
Top down cortical control of hypothalamic feeding circuits
Professor Zane Andrews from Monash Biomedicine Discovery Institute
Circadian clock, sleep, and depression in adolescence: Modelling a novel pathway
Dr Bei Bei from the Turner Institute for Brain and Mental Health
Neuropharmacology of decision-making: causal brain network modelling across species
Professor Mark Bellgrove from the Turner Institute for Brain and Mental Health
Can psychedelics treat anorexia nervosa? Insights into the therapeutic effects of psilocybin in an animal model
Dr Claire Foldi from Monash Biomedicine Discovery Institute
Building an Evidence-Base to inform Post-Traumatic Stress Disorder (PTSD) Treatment for Culturally and Linguistically Diverse Communities
Associate Professor Laura Jobson from the Turner Institute for Brain and Mental Health
Precursor neurons on standby fast track neural repair
Associate Professor Jan Kaslin from Australian Regenerative Medicine Institute
Machine learning models for personalised epilepsy management
Professor Patrick Kwan from Central Clinical School
Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia
Dr Sarah Lockie from the Turner Institute for Brain and Mental Health
Brain injury in intimate partner violence: Insight into a silent pandemic
Associate Professor Sandy Shultz from Central Clinical School.
Glioblastoma - inhibition of P2X7R as a potential therapeutic target for treatment of this aggressive cancer
Dr. Mastura Monif from Central Clinical School
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.